A group of plaintiffs who sued Johnson & Johnson‘s (NYSE:JNJ) DePuy Orthopaedics in a bellwether case over alleged defects associated with its Pinnacle metal-on-metal hips are looking for approximately $246.1 million in damages, according to recently released court documents. The damages come after a jury in Texas federal court ruled in favor of the plaintiffs, […]
depuysynthes
J&J seeks retraction of paper critical of Pinnacle hip study
Johnson & Johnson (NYSE:JNJ) are looking to get a scholarly paper challenging the validity an internal study of its DePuy subsidiary’s Pinnacle metal-on-metal hip systems retracted, according to a Stat News report. The study and journal paper were published by Brown University’s Dr. David Egilman and accused the J&J study of “grave fraudulence,” according to the […]
Johnson & Johnson launches new self-shortening Dynacord suture
Johnson & Johnson through its DePuy Synthes franchise has announced the U.S. launch of its Dynacord suture for soft tissue repair in areas such as the rotator cuff in the shoulder. The Dynacord suture, available on Healix Advance anchors, is part of the DePuy Synthes Mitek Sports Medicine portfolio. J&J launched Dynacord today at the San […]
DePuy Synthes launches Global Unite reverse fracture shoulder implant
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced the launch of the Global Unite reverse fracture shoulder implant designed for shoulder reconstruction procedures following complex fractures in patients with grossly deficient rotator cuffs. The newly launched system is intended to provide increased flexibility for securely reattaching the bone to the implant, which DePuy Synthes said is important […]
DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes late last week released new data on its Attune knee system from a study and internal report, touting potential benefits of the system. The company released data from a study of the Attune knee implant comparing it to preoperative baseline at six months. Data from the study indicated a statistically […]
J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked a deal to acquire the assets of Medical Enterprises Distribution, including its automated ME1000 surgical impactor designed for hip replacements, for an undisclosed amount. DePuy said that it expects the deal to close during the second quarter of this year, and that the deal is still subject […]
Judge limits damages to last 4 years in DePuy patent spat
A US District Judge last week capped damages in an orthopedic device patent infringement case against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes, limiting damages to the last four years. In the case, plaintiff Acantha accused DePuy of infringing on a patent with its Vector and Zero-P VA product lines. The patent was issued originally in 2001, […]
7 medtech stories we missed this week: April 27, 2018
From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed […]
13 orthopedic products from AAOS 2018 you need to know
The American Academy of Orthopedic Surgeons’s annual meeting is an opportunity for industry professional to come together and showcase some of their latest orthopedic solutions, research and technology. The meeting is being held in New Orleans at the Morial Convention Center, March 6-10. This year, a number of orthopedic companies have launched some of their latest […]
J&J’s DePuy Synthes touts anterior-approach results in comparative THA study
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today touted results from a systemic review of prospective studies comparing postoperative outcomes of both anterior and posterior approaches to total hip arthroplasty procedures. Results from the study, which were published in The Journal of Arthroplasty, indicated that the anterior approach results in increases in hip function and reduction in […]
Revision rates prompt recalls for Johnson & Johnson’s DePuy Synthes, Zimmer Biomet
High revision rates for orthopedic implants prompted recalls in recent months for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes and Zimmer Biomet (NYSE:ZBH). Last month DePuy Synthes recalled a stand-alone element of its Sigma HP partial knee replacement, the Sigma HP PFJ cemented trochlear implant, “based on elevated revision rates observed as part of the company’s post-market surveillance […]